Poly(ADP-ribose) polymerase inhibition improves erectile function by activation of nitric oxide/cyclic guanosine monophosphate pathway in diabetic rats.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Sexual Medicine

• Publication date

  2012-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1743-6109.2012.02666.xPMID 22429732
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New Treatment Options for Erectile Dysfunction in Patients with Diabetes Mellitus

  2012cited by this paper
• Poly(ADP-Ribose) polymerase inhibition improves erectile function in diabetic rats.

  2011cited by this paper
• Chronic treatment with an oral rho-kinase inhibitor restores erectile function by suppressing corporal apoptosis in diabetic rats.

  2011cited by this paper
• PARP inhibition restores erectile function by suppressing corporal smooth muscle apoptosis in diabetic rats.

  2011cited by this paper
• Reactive oxygen species and endothelial function in diabetes.

  2010cited by this paper
• Poly(ADP-ribose) polymerase inhibition reverses nitrergic neurovascular dysfunctions in penile erectile tissue from streptozotocin-diabetic mice.

  2010cited by this paper
• Sildenafil inhibits superoxide formation and prevents endothelial dysfunction in a mouse model of secondhand smoke induced erectile dysfunction.

  2009cited by this paper
• Restoring erectile function by antioxidant therapy in diabetic rats.

  2009cited by this paper
• Erectile dysfunction in diabetes mellitus.

  2009cited by this paper
• Increased expression of the nitric oxide synthase gene and protein in corpus cavernosum by repeated dosing of udenafil in a rat model of chemical diabetogenesis.

  2009cited by this paper
• Review type 2 diabetes mellitus and erectile dysfunction.

  2009cited by this paper
• PARP-1 inhibition-induced activation of PI-3-kinase-Akt pathway promotes resistance to taxol.

  2009cited by this paper
• Protective Effects of PARP-1 Knockout on Dyslipidemia-Induced Autonomic and Vascular Dysfunction in ApoE−/− Mice: Effects on eNOS and Oxidative Stress

  2009cited by this paper
• PARP-1 Inhibition Prevents Oxidative and Nitrosative Stress–Induced Endothelial Cell Death via Transactivation of the VEGF Receptor 2

  2008cited by this paper
• Endothelial rehabilitation: the impact of chronic PDE5 inhibitors on erectile function and protein alterations in cavernous tissue of diabetic rats.

  2008cited by this paper
• PARP mediates structural alterations in diabetic cardiomyopathy.

  2008cited by this paper
• Inflammation and endothelial dysfunction during aging: role of NF-kappaB.

  2008cited by this paper
• Improved spontaneous erectile function in men with mild-to-moderate arteriogenic erectile dysfunction treated with a nightly dose of sildenafil for one year: a randomized trial.

  2007cited by this paper
• PARP inhibitor development for systemic cancer targeting.

  2007cited by this paper
• EAU Guidelines on erectile dysfunction: an update.

  2006cited by this paper
• Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited.

  2005cited by this paper
• The pathogenesis of diabetic complications: the role of DNA injury and poly(ADP-ribose) polymerase activation in peroxynitrite-mediated cytotoxicity.

  2005cited by this paper
• Poly(Adenosine diphosphate-ribose) polymerase inhibition preserves erectile function in rats after cavernous nerve injury.

  2005cited by this paper
• ORIGINAL RESEARCH—BASIC SCIENCE: Superoxide Anion Production in the Rat Penis Impairs Erectile Function in Diabetes: Influence of In Vivo Extracellular Superoxide Dismutase Gene Therapy

  2005cited by this paper
• Role of Poly(ADP-Ribose) Polymerase-1 Activation in the Pathogenesis of Diabetic Complications: Endothelial Dysfunction, as a Common Underlying Theme

  2005cited by this paper
• Pivotal Role of Akt Activation in Mitochondrial Protection and Cell Survival by Poly(ADP-ribose)polymerase-1 Inhibition in Oxidative Stress*

  2005cited by this paper
• Erection Capability Is Potentiated by Long-Term Sildenafil Treatment: Role of Blood Flow-Induced Endothelial Nitric-Oxide Synthase Phosphorylation

  2005cited by this paper
• Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors

  2005cited by this paper
• Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk.

  2005cited by this paper
• Roles of poly(ADP-ribose) polymerase activation in the pathogenesis of diabetes mellitus and its complications.

  2005cited by this paper
• Phosphodiesterase type 5 inhibitors for erectile dysfunction

  2005cited by this paper
• Polyadenosine diphosphate-ribose polymerase inhibition modulates skeletal muscle injury following ischemia reperfusion.

  2005cited by this paper
• NO generation from nitrite and its role in vascular control.

  2005cited by this paper
• Point of NO return for nitrergic nerves in diabetes: a new insight into diabetic complications.

  2004cited by this paper
• Efficacy and tolerability of tadalafil, a novel phosphodiesterase 5 inhibitor, in treatment of erectile dysfunction.

  2003cited by this paper
• Diabetes‐induced overexpression of endothelin‐1 and endothelin receptors in the rat renal cortex is mediated via poly(ADP‐ribose) polymerase activation

  2003cited by this paper
• Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease.

  2003cited by this paper
• Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study.

  2003cited by this paper
• Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats.

  2003cited by this paper
• Effect of poly(ADP ribose) synthetase inhibition on burn and smoke inhalation injury in sheep.

  2002cited by this paper
• Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus

  2002cited by this paper
• The clinical studies of sildenafil for the ageing male.

  2002cited by this paper
• Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation

  2001cited by this paper
• Rapid Reversal of the Diabetic Endothelial Dysfunction by Pharmacological Inhibition of Poly(ADP-Ribose) Polymerase

  2001cited by this paper
• Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation

  2001cited by this paper
• Reference values for young normal Sprague-Dawley rats: weight gain, hematology and clinical chemistry

  1996cited by this paper

• Revisiting experimental models of erectile dysfunction and their value in drug discovery and development

  2025cites this paper
• Mode of cell death in the penile cavernous tissue of type 1 diabetes mellitus rats.

  2024cites this paper
• Pyroptosis and inflammation‑mediated endothelial dysfunction may act as key factors in the development of erectile dysfunction (Review)

  2023cites this paper
• Current status and prospects of diabetes mellitus induced erectile dysfunction: A bibliometric and visualization study

  2023cites this paper
• Low androgen status inhibits erectile function by increasing pyroptosis in rat corpus cavernosum

  2021cites this paper
• Cerebral Vasodilator Property of Poly(ADP-Ribose) Polymerase Inhibitor (PJ34) in the Neonatal and Adult Mouse Is Mediated by the Nitric Oxide Pathway

  2020cites this paper
• Penile alterations at early stage of type 1 diabetes in rats

  2017cites this paper
• Doxorubicin-induced necrosis is mediated by poly-(ADP-ribose) polymerase 1 (PARP1) but is independent of p53

  2015cites this paper
• Abnormal lipid metabolism down‐regulates adenosine triphosphate synthase β‐subunit protein expression in corpus cavernosum smooth muscle in vitro and in vivo

  2014cites this paper
• Review of erectile dysfunction in diabetic animal models.

  2014cites this paper
• Treatment of erectile dysfunction: new targets and strategies from recent research.

  2014cites this paper
• Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

  2013cites this paper
• Assessment of the efficacy of combination therapy with folic acid and tadalafil for the management of erectile dysfunction in men with type 2 diabetes mellitus.

  2013cites this paper